- Home
- ADCT vs DSP Comparison
ADCT vs DSP Comparison
Compare ADCT & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- DSP
- Stock Information
- Founded
- ADCT 2011
- DSP 1999
- Country
- ADCT Switzerland
- DSP United States
- Employees
- ADCT N/A
- DSP N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- DSP EDP Services
- Sector
- ADCT Health Care
- DSP Technology
- Exchange
- ADCT Nasdaq
- DSP Nasdaq
- Market Cap
- ADCT 241.0M
- DSP 220.3M
- IPO Year
- ADCT 2020
- DSP 2021
- Fundamental
- Price
- ADCT $3.17
- DSP $13.06
- Analyst Decision
- ADCT Strong Buy
- DSP Strong Buy
- Analyst Count
- ADCT 6
- DSP 8
- Target Price
- ADCT $7.80
- DSP $21.75
- AVG Volume (30 Days)
- ADCT 913.9K
- DSP 207.7K
- Earning Date
- ADCT 08-05-2025
- DSP 08-11-2025
- Dividend Yield
- ADCT N/A
- DSP N/A
- EPS Growth
- ADCT N/A
- DSP N/A
- EPS
- ADCT N/A
- DSP 0.13
- Revenue
- ADCT $75,817,000.00
- DSP $306,484,000.00
- Revenue This Year
- ADCT $11.75
- DSP $18.36
- Revenue Next Year
- ADCT $10.29
- DSP $15.95
- P/E Ratio
- ADCT N/A
- DSP $105.20
- Revenue Growth
- ADCT 10.49
- DSP 30.64
- 52 Week Low
- ADCT $1.05
- DSP $8.70
- 52 Week High
- ADCT $4.13
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- ADCT 59.73
- DSP 55.14
- Support Level
- ADCT $2.66
- DSP $12.79
- Resistance Level
- ADCT $3.30
- DSP $13.85
- Average True Range (ATR)
- ADCT 0.20
- DSP 0.52
- MACD
- ADCT 0.01
- DSP 0.13
- Stochastic Oscillator
- ADCT 90.00
- DSP 86.80
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.